{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:51:44Z","timestamp":1781877104909,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271492"],"award-info":[{"award-number":["82271492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04944-z","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:33:52Z","timestamp":1777642432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CACNA1A c.5610del in a three-generation family: epilepsy with ataxia\/migraine"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhongyuan","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisen","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"3","key":"4944_CR1","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1016\/S2468-2667(24)00302-5","volume":"10","author":"GBD Epilepsy Collaborators","year":"2025","unstructured":"GBD Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health. 2025;10(3):e203\u201327.","journal-title":"Lancet Public Health"},{"issue":"9","key":"4944_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/s41588-023-01485-w","volume":"55","author":"International League Against Epilepsy Consortium on Complex Epilepsies","year":"2023","unstructured":"International League Against Epilepsy Consortium on Complex Epilepsies. GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture. Nat Genet. 2023;55(9):1471\u201382.","journal-title":"Nat Genet"},{"issue":"12","key":"4944_CR3","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1111\/jnc.15983","volume":"168","author":"RJ Lauerer","year":"2024","unstructured":"Lauerer RJ, Lerche H. Voltage-gated calcium channels in genetic epilepsies. J Neurochem. 2024;168(12):3853\u201371.","journal-title":"J Neurochem"},{"issue":"1","key":"4944_CR4","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1038\/s41467-023-43475-w","volume":"14","author":"M Sampedro-Castaneda","year":"2023","unstructured":"Sampedro-Castaneda M, et al. Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability. Nat Commun. 2023;14(1):7830.","journal-title":"Nat Commun"},{"issue":"1","key":"4944_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41572-021-00328-4","volume":"8","author":"MD Ferrari","year":"2022","unstructured":"Ferrari MD, et al. Migraine Nat Rev Dis Primers. 2022;8(1):2.","journal-title":"Migraine Nat Rev Dis Primers"},{"key":"4944_CR6","doi-asserted-by":"crossref","unstructured":"Hassan A, Ataxias E. Primary and Secondary Etiologies, Treatment, and Classification Approaches. Tremor Other Hyperkinet Mov (N Y), 2023. 13: p. 9.","DOI":"10.5334\/tohm.747"},{"key":"4944_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejpn.2021.05.010","volume":"33","author":"M Le Roux","year":"2021","unstructured":"Le Roux M, et al. CACNA1A-associated epilepsy: Electroclinical findings and treatment response on seizures in 18 patients. Eur J Paediatr Neurol. 2021;33:75\u201385.","journal-title":"Eur J Paediatr Neurol"},{"issue":"11","key":"4944_CR8","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/ejhg.2015.21","volume":"23","author":"L Damaj","year":"2015","unstructured":"Damaj L, et al. CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet. 2015;23(11):1505\u201312.","journal-title":"Eur J Hum Genet"},{"key":"4944_CR9","doi-asserted-by":"publisher","first-page":"946","DOI":"10.12659\/MSM.912359","volume":"25","author":"R Pan","year":"2019","unstructured":"Pan R, et al. Correlations of Calcium Voltage-Gated Channel Subunit Alpha1 A (CACNA1A) Gene Polymorphisms with Benign Paroxysmal Positional Vertigo. Med Sci Monit. 2019;25:946\u201351.","journal-title":"Med Sci Monit"},{"issue":"4","key":"4944_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"4944_CR11","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.1007\/s00415-024-12602-y","volume":"271","author":"E Indelicato","year":"2024","unstructured":"Indelicato E, et al. Natural history of non-polyglutamine CACNA1A disease in Austria. J Neurol. 2024;271(10):6618\u201327.","journal-title":"J Neurol"},{"key":"4944_CR12","doi-asserted-by":"publisher","first-page":"1222321","DOI":"10.3389\/fnmol.2023.1222321","volume":"16","author":"M Kessi","year":"2023","unstructured":"Kessi M, et al. The genotype-phenotype correlations of the CACNA1A-related neurodevelopmental disorders: a small case series and literature reviews. Front Mol Neurosci. 2023;16:1222321.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"4944_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1523\/JNEUROSCI.2555-15.2016","volume":"36","author":"VC Bomben","year":"2016","unstructured":"Bomben VC, et al. Isolated P\/Q Calcium Channel Deletion in Layer VI Corticothalamic Neurons Generates Absence Epilepsy. J Neurosci. 2016;36(2):405\u201318.","journal-title":"J Neurosci"},{"key":"4944_CR14","doi-asserted-by":"crossref","unstructured":"Leitch B. Molecular Mechanisms Underlying the Generation of Absence Seizures: Identification of Potential Targets for Therapeutic Intervention. Int J Mol Sci, 2024. 25(18).","DOI":"10.3390\/ijms25189821"},{"issue":"3","key":"4944_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/epi.17842","volume":"65","author":"M Alshakhouri","year":"2024","unstructured":"Alshakhouri M, et al. Female sex steroids and epilepsy: Part 1. A review of reciprocal changes in reproductive systems, cycles, and seizures. Epilepsia. 2024;65(3):556\u201368.","journal-title":"Epilepsia"},{"key":"4944_CR16","doi-asserted-by":"crossref","unstructured":"Subbamanda YD, Bhargava A. Intercommunication between Voltage-Gated Calcium Channels and Estrogen Receptor\/Estrogen Signaling: Insights into Physiological and Pathological Conditions. Cells, 2022. 11(23).","DOI":"10.3390\/cells11233850"},{"key":"4944_CR17","first-page":"263300402412457","volume":"5","author":"PM Fox","year":"2024","unstructured":"Fox PM, et al. Developing a pathway to clinical trials for CACNA1A-related epilepsies: A patient organization perspective. Ther Adv Rare Dis. 2024;5:26330040241245725.","journal-title":"Ther Adv Rare Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04944-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04944-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04944-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:03:41Z","timestamp":1781874221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04944-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4944"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04944-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine (Approval No. G2025-23). Written informed consent to participate was obtained from all participants. For participants younger than 16 years, written informed consent was obtained from their parents or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of personal and clinical details, along with any potentially identifying images including pedigree information, was obtained from all participants\/patients. For participants under 18 years of age, written informed consent was obtained from their parents or legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"400"}}